Monsel, A., Hauw-Berlemont, C., Mebarki, M., Heming, N., Mayaux, J., Tchoumba, O. N., . . . Group, A. S. C. R. (2022). Treatment of COVID-19-associated ARDS with mesenchymal stromal cells. Critical Care, 26(1), 1. https://doi.org/10.1186/s13054-022-03930-4
Chicago-referens (17:e uppl.)Monsel, Antoine, et al. "Treatment of COVID-19-associated ARDS with Mesenchymal Stromal Cells." Critical Care 26, no. 1 (2022): 1. https://doi.org/10.1186/s13054-022-03930-4.
MLA-referens (9:e uppl.)Monsel, Antoine, et al. "Treatment of COVID-19-associated ARDS with Mesenchymal Stromal Cells." Critical Care, vol. 26, no. 1, 2022, p. 1, https://doi.org/10.1186/s13054-022-03930-4.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.